EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS176-17398 
Organism
Homo sapiens 
Tissue/cell
SK-N-SH 
Coordinate
chr17:76710240-76713010 
TF binding sites/motifs
Number: 1             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
GLI2MA0734.2chr17:76711275-76711290AGACCACCCACGAGG+7.15
Number of super-enhancer constituents: 32             
IDCoordinateTissue/cell
SE_03593chr17:76711023-76712412Brain_Angular_Gyrus
SE_03593chr17:76712585-76716199Brain_Angular_Gyrus
SE_04177chr17:76710362-76716568Brain_Anterior_Caudate
SE_05030chr17:76709033-76722335Brain_Cingulate_Gyrus
SE_06197chr17:76709480-76716750Brain_Hippocampus_Middle
SE_07013chr17:76709128-76722223Brain_Hippocampus_Middle_150
SE_08280chr17:76709155-76716729Brain_Inferior_Temporal_Lobe
SE_09291chr17:76711164-76712866CD14
SE_10232chr17:76710234-76716463CD19_Primary
SE_10917chr17:76699585-76716888CD20
SE_14447chr17:76710268-76711913CD4_Memory_Primary_7pool
SE_16882chr17:76711114-76712183CD4p_CD225int_CD127p_Tmem
SE_17330chr17:76710288-76716652CD4p_CD25-_CD45RAp_Naive
SE_17789chr17:76710408-76716366CD4p_CD25-_CD45ROp_Memory
SE_18275chr17:76708858-76756450CD4p_CD25-_Il17-_PMAstim_Th
SE_19133chr17:76710328-76716614CD4p_CD25-_Il17p_PMAstim_Th17
SE_20047chr17:76710271-76713495CD56
SE_22344chr17:76709216-76716514CD8_primiary
SE_26201chr17:76711511-76713321Duodenum_Smooth_Muscle
SE_32461chr17:76709187-76716237GM12878
SE_39457chr17:76710273-76715896Jurkat
SE_43543chr17:76711343-76716562MM1S
SE_49999chr17:76711125-76716429RPMI-8402
SE_52658chr17:76712722-76715493Small_Intestine
SE_53636chr17:76711249-76712312Spleen
SE_59073chr17:76687338-76733905Ly3
SE_60415chr17:76679151-76756346DHL6
SE_60995chr17:76690240-76779668HBL1
SE_61668chr17:76693174-76787177Toledo
SE_62236chr17:76690401-76817069Tonsil
SE_66337chr17:76710273-76715896Jurkat
SE_67253chr17:76711343-76716562MM1S
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr177671128376712268
Enhancer Sequence
GCACACCTGT AATCCCAGCT ACTTGGGAGG CTGAGACAAG AGAATCGCTT GAACCCCAGA 60
GGTGGAGGTT GCAGTGAGCC AAGATGGCAA CGTTGCACTC CAGCCTGGGC AACAGAGCAG 120
GCCTCCATCT CAAAAAAATT TAAAAATTTA AAAAAAATAG TAAAGGAACA AAAACATCCA 180
TAAACCTACA ATATCAAAGA GTACACAGAG AAGGGCCATC AGAAGAGATT TCAACAAATT 240
TCCAGAACAG AGAAAGGAAA GAAACAGTGC TAAGTGCTAA TATCTTCTAG AATAAAAACT 300
CCACAAAGGC AGGGACACCG TATGCCTTGT ACACTGTTGT GTTTGTGGTA CTCAGCACAG 360
GGCCTAGCAC ACTAAGGATT TCACACACAC ACACAAACAC ACACACATGA ACGAAGCCAA 420
CTTTCTCATG AGCAGACAAG TGTGGAGCTG GTGTCCAGGG TAAAGCCTCC ATATGTAGAC 480
AGCGGACACC TAAGAGAACC CTACCCCAAG CAGGCTCTGG CTCACTCGCC CTGAAGCCAA 540
GCCTCCCTGC CCACAAGGCC CAGCCATGCA CAGAGCTTCC GCTTAACATG TCTACTGCTT 600
CACTCTTACA CTTACAGAGA TAACCACACC TATGCCAGGA GTGAGAAAGG ACAAGACAGG 660
GAACAGAAAA CTCACCCTAG AGCAAACAGA GATAATTAGG GGGAAAAAAG AAAGAAAAAA 720
AAAACCTTTA AAAGAACAGA AAACTCTGGA AAAGGGACAA TTACAGAAAA AGAATACGGC 780
CTTGCAAATT AAACATACTT TTGTCCCCCA CATCAAAAAA GTCAACGAAG GATTAAAAGA 840
TAAAGTTGGG GCATTCCTGT AGAACAAAGA GGTTTGAAAA TATAAGCAAA CCTGGAAATA 900
TAAGCAAAAA AATAAACTCG GTTGAATAAA AATATTTTTA AATCCCACAG AGAAATTCTC 960
ATAGGAAAAA TTCAGAAGTT CCAGGAATAA AGACGATCCT AAAACCTCCA CAGAGGTTAA 1020
GGAGAGTGAT TAATCAGACC ACCCACGAGG GAAGATCTCG CTGGTGTCAG TATAAGAGCC 1080
CGCACACTAA AGATAGCGCA GTGGAACTTT CAAAATTCTA AATGAAAATT ATCTGAACCC 1140
CAAATTCTCA GTCAAGTAGG AGGGTAAAAC AGACTCATTT CAGATACATA AGGATCAGAA 1200
AGTTTGTCTT CTGTGCACCC CTTCTGAAGA AGCTACTTCA GGAGCAAGAT GTGGATCAAG 1260
GAACGGGACT GACTCAGGAG CCTGAGGACA GCAAGCGCCA TCAACTGTGA TGGCCAACAG 1320
CCACCAGACC GGGTCAGAGC AGGAAGCCAA AGGGCTGCCA GAGGAATGCC ATCAGAAAGA 1380
ATGAAATCAG ACTCGAAACC AGAGAATGAA GGAGAAAGCA GCTGAGAAAA CTGTGTGATA 1440
CCAACAGGCA TCATTCGGTT TCCTCTCAAG AGAATAAAAA GGACTGGGCA ACAGGAAAAA 1500
CTCAACTACA GGAAATCACA GAAGAAATGA AACATGCCCC CCGAGTGGTG TCCTCTGGGC 1560
CATCAGGGAC GCCAGGAACA GCTCCCTTTG AGTGGGCACC TGGCTCTACG GTGAGTGGTA 1620
TCTACATTCC TGTCATGGTG CTGGTCGCTG GTAGTTAACT TACAGAATCA CCCTGTAGAC 1680
AAAGCATGAA AGACCAACCC AGGCTGGAGA AGCAAAGCTA TCTGTTACCA AGGTGAAGGA 1740
AGAGCTGACC AAAGTTTGAG GGAAGCAAAG TGGAGAGGGC AGCAGGGTCC CAAATGGTCC 1800
CCACAGCTTC CTCCTACAAC ACTAGAGACC AGAGGCATGG ATAAGGATCA TGAACAAGAA 1860
ACCCACGCTG TAAATATGCC AAAGGTAAAA ATCCAGGAAC TGAAAATTGT GATCAACTAC 1920
CAAAAATGGA CAGTGAGAGA AGGAAGGAAG AGAATGGTGT GAGCTGCATC CTCATCCATC 1980
ATAGGCAGAA GGCAGGAGAT AACCTTTGAT CTTGACAAAA TAATCACCAA TTTAAGAACT 2040
TGGCAGCACC CACTAGAAGA CCTAAAAGCA GAAAAAAGTG AATTAATAGT GGCTGCTTTG 2100
GGGAGTGGGT CTGGGAATAG AGAGACAGGA CATATAAGCC CCTGAATACT TGCTTTAAAA 2160
TACATATATA TATGTACTAT GACAATTTGA AAACAAAAGA CTAAAAATGT ACAACTATGG 2220
TCACTAGAAA AGATAGCCCT TCTGTGTCCT TGGAGTCAGA CAGAAAACGC TTCTGGCCAA 2280
TTTGTAGCTA GAATAAATAA GACATTTATC TACATTTATT TTGATCCAAT CTCCTGACAT 2340
TTGCCACATG ACTGCTAAAT TACTTCTCCA TTCCATACTT ACTAACTTTA AATCATAATG 2400
CTGCTCCCCT TCTGGCTCAA CCAATCATTC AAGAACTTTA TTTTAAAAAG CTGAACTACA 2460
CCTCATTTTT CTAGTGGAAT TTTATTCTGA GATGAGGCAA AATCTAATAT TTTAATAAGT 2520
ATTTTCCTCT GCATAAACTT AACAATGCAA CATCAAATCT TTAATTCAAG CCTTCATTCT 2580
CATGCTGCCC CGGACAGAAA AAACATCCAA AAACAAAATG CTTAATTTCA TTTAGCAGCA 2640
TGAAGAATCA ACACTATTGC TGGAGAGCTG AGGTGTGATT GATTCCTACA GTCTTGGCTA 2700
GTGTCTTCAG GACACTGCGA AGGCCACAGC TGGAACAAGA AAGGTGGTGG TCAGAAATAC 2760
CCATGTCTAC 2770